【AHEALTH 7090 交流专区】艾柏士保健

yatlokfatt

终于宣布它的4.5sen的终期及10sen的特别股息了。
EX－DATE：31/5/2010
Final dividend of 4.5 sen gross per share less tax and a special dividend of 10.0 sen gross per share less tax for the financial year ended 31 December 2009.

lengleng28

yatlokfatt兄谢谢你的分享，我现在已经赚不少了，几时要卖记得通知哦

penangist

yatlokfatt兄在之前分享的KKB，YEELEE ＆ AHEALTH都是有不错的回酬。
http://cforum1.cari.com.my/viewthread.php?tid=1607564&highlight=kkb

http://cforum1.cari.com.my/viewthread.php?tid=1874594&extra=page%3D1

lengleng28

想问下红股几时分？

belle888

想问下红股几时分？
lengleng28 发表于 4-6-2010 11:45 AM

LISTING'S CIRCULAR NO. L/Q :  57376 OF  2010

BONUS ISSUE OF 18,743,375 NEW ORDINARY SHARES OF RM1.00 EACH IN APEX HEALTHCARE

BERHAD ("AHB SHARES") ("BONUS SHARES") ON THE BASIS OF ONE (1) BONUS SHARE FOR

EVERY FOUR (4) EXISTING AHB SHARES.

Kindly be advised of the following :

1)  The above Company's securities will be traded and quoted [ "Ex - Bonus

Issue" ]

as  from : [ 16 June 2010 ]

2)  The last date of lodgement : [ 18 June 2010 ]

3)  Retention Money :  Where securities are not delivered in time for

registration by the seller, then the brokers concerned :-

a)  Selling Broker to deduct [ 1/5 ] , of the Selling Price against the

Selling Client.

b)  Buying Broker to deduct [ 20% ] of the Purchase Price against the

Buying Client.

c)  Between Broker and Broker, the deduction of [ 1/5 ] of the Transacted

Price is applicable.

Remarks :-  A maximum of 18,743,375 Bonus Shares will be allotted and issued on

the basis of one (1) Bonus Share for every four (4) existing AHB Shares held at

5.00 p.m. on 18 June 2010.

hui0909

请问这股目标价是多少丫

tungstar

Apex Healthcare proposes 1-for-4 bonus issue 。买1000lots  可以得到多少bonus

hello2009

回复 27# tungstar


买1000lots  可以得到250lots的bonus

水星

分股后还是这么高价位，叫我如何进场？

yatlokfatt

再一次报出亮眼的业绩－

kennedyy2k

谢谢介绍 。。。。。。。。

shinchan326

再一次报出亮眼的业绩－
yatlokfatt 发表于 21-8-2010 12:06 AM

期待拜一开市。。

silverdawn

回复 32# shinchan326


    难道你买了很多?

shinchan326

回复  shinchan326


    难道你买了很多?
silverdawn 发表于 22-8-2010 12:07 AM

    没有。。可是还是会期待啊。

engguan

现在价格多少
目标价???

shinchan326

现在价格多少
目标价???
engguan 发表于 22-8-2010 03:19 PM

    不是很会算。。不过打算长期持有。。

yatlokfatt

正向RM3目标前进....

yatlokfatt

以下是AHEALTH在2010财政年的一些主要关键数据：

yatlokfatt

2011年度首季度业绩继续标青：

TheGroup‟s revenue for the first quarter of 2011 is RM92.8million and its profit before tax is RM11.6million, representing increases of 20% and 31% respectively over the result for the same quarter in the last financial year.

Revenue at Xepa-Soul Pattinson(M) Sdn Bhd‟s(„Xepa&#8223exceeded budget and grew18%quarter on quarter, driven by continued robust sales to private sector clinics, pharmacies and hospitals in the domestic sector. In anticipation of growing demand, Xepa has embarked on a  freshRM4 million capital expenditure program to increase capacity, automation and improve manufacturing efficiency.

Apex Pharmacy Marketing Sdn Bhd＇s revenue for the current quarter grew 22%compared to the same period last year due to good contributions from all four divisions; logistics, consumer, pharma & diagnostics and wholesale. Newly launched Avegesic 15mg under the Group‟s AVEX brand has been well received by the market. In Singapore, revenue grew by 23% year on year to RM17.3 million for the quarter, driven by newly acquired distribution agencies and wholesale.

yatlokfatt

刚又汇报出亮眼的成绩，FY11上半年EPS＝16.49sen而且建议派发5.5sen的中期股息

THE SECOND QUARTER ENDED 31 DECEMBER 2011
Review of Performance
For the six months to June 2011, AHB Group recorded a profit before tax of RM 20.4 million on revenues of RM 182 million. These represent respectively a 27% and 6%growth over the that recorded for the first half of financial year 2010. For the second quarter of 2011,revenue and profit before tax is RM89million and RM8.8million respectively, which is a growth of 15% and 12%over that achieved for the same period last year.

Carried by the strong sales momentum in the first quarter, Xepa-Soul Pattinson(M)Sdn Bhd achieved record performance levels for both revenue and profit for the first half year. The good performance is attributed to continued strong sales domestically in both the private and public sectors upon the successful outcome of its prmotional launches and local trade fairs. Operating synergies were further enhanced with the streamlining of domestic distribution coverage under Apex Pharmacy Marketing Sdn Bhd.

Revenue and profit at Apex Pharmacy Marketing Sdn Bhd likewise grew steadily,with continued good market acceptance of newly launched own-brand products.These include AvoMeter Perfect,a combination blood glucose and total cholesterol meter under the Group’s Avo Diagnostics brand. Newly acquired agencies contributed to sustain growth in pharmaceutical distribution operations in Singapore.